Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Cory S. Freedland currently holds 12,050 shares of Neurogene Inc. (NGNE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Cory S. Freedland has been a net neutral trader of NGNE stock. They have purchased $0 and sold $0 worth of shares.
Cory S. Freedland's most recent insider trade was on Feb 20, 2026, when they sold 12,050 shares at $0.00 per share.
Cory S. Freedland serves as Executive at Neurogene Inc. (NGNE). They have executed 3 insider transactions totaling $0 over their tenure at the company.
Cory S. Freedland holds the position of Executive at Neurogene Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Cory S. Freedland has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Cory S. Freedland was on Feb 20, 2026, when they purchased $0 worth of NGNE shares. This transaction involved 12,050 shares at N/A per share.
Cory S. Freedland currently owns 12,050 shares of Neurogene Inc. (NGNE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Cory S. Freedland's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Cory S. Freedland has 3 Form 4 filings on record as an insider at Neurogene Inc..
Set alerts for Cory S. Freedland and 40,000+ other insiders.